Arthur Gutierrez-Hartmann, MD was born in Mexico City and grew up in San Antonio, Texas, with Spanish as his first language. He received a BA in Chemistry in 1971 from the University of Texas at Austin, and then graduated with an MD from the University of Texas Southwestern Medical School (UTSW) in 1975. From 1971-1977, he also pursued graduate studies purifying yeast citrate synthase from yeast mitochondria in Dr. Ron Butow’s lab in the Biochemistry Dept at UTSW. From 1977-80, he completed Internal Medicine residency training at Stanford University Hospital, and from 1980-83, he completed a Molecular Endocrinology training fellowship with Dr. John Baxter at UCSF. After an initial faculty position at UCSF (1983-85), he was recruited to the University of Colorado HSC in 1985, where he was a founding member of the MD/PhD Training Program (1985; now MSTP), the Molecular Biology Graduate Program (1986), the Cancer Center (1987), the Reproductive Biology Graduate Program (2004), the CCTSI TL1 (2008), and the Physician-Scientist Training Program (2011). Arthur has served in leadership positions in national associations dealing with graduate and physician-scientist training, on Council of the American Cancer Society (ACS), and he serves on multiple editorial boards, including Associate Editor of Molecular Endocrinology. Arthur has been selected for many awards and visiting professorships, including: an A. P. Giannini/Bank of America Fellowship; a PEW Scholar Award in the Biomedical Sciences; elected to the American Society of Clinical Investigation; a NSF-CNRS Visiting Scientist, IGBMC, Illkirch, France; the 2002 SACNAS Distinguished Scientist of the Year Award; the 2008 AACR Jane Coffin Wright - Minority in Cancer Research Award; the 2009 Endocrine Society’s Distinguished Educator Award; and the inaugural ASBMB 2010 Ruth Kirchstein Diversity in Science Award. The main focus of the AGH laboratory is to determine the role of ETS transcription factors in epithelial cell development and tumorigenesis, with a focus on pituitary mammary and GI model systems. He has been supported by NIH R01 grants to pursue this research work, with PEW, ACS, DOD and NSF also providing support. As a clinician he attends patients with endocrine disorders, focusing on pituitary tumors and thyroid cancer. Finally, Arthur has been highly committed to the recruitment and training of women and underrepresented students to all aspects of the biomedical workforce.